Co-transfection of HSC with this β-globin transgene and ribonucleoprotein containing sgRNA designed to delete the HBA2 gene resulted in an improvement of α/β globin chain to near-normal levels in erythroid cells of patients with β+-thalassaemia and β0-thalassaemia. The gene discussed is HBA2; the disease is thalassemia.